KALMANGAFODIPIR, NEW CHEMICAL COMPOUND AND OTHER MIXED COMPLEX COMPOUNDS WITH METALS, METHODS FOR PREPARATION, COMPOSITIONS AND TREATMENT METHODS Russian patent published in 2017 - IPC C07F19/00 A61K31/555 A61P35/00 

Abstract RU 2622646 C2

FIELD: chemistry.

SUBSTANCE: invention relates to a mixed complex metal compound containing calcium and manganese in the form of a complex with a formula I compound or a pharmaceutically acceptable salt thereof: formula I. In formula I the radicals have the following meanings: X is CH, each R1 independently represents -CH2COR5, R5 represents hydroxy, each R2 independently represents ZYR6, where Z represents C1-3alkylene group, Y represents a bond, R6 represents OR8 or OP(O)(OR8)R7, R7 represents hydroxy or an unsubstitutedC1-6alkyl or aminoalkyl group, R8 represents a hydrogen atom or a C1-6alkyl group, R3 represents an ethylene group, and each R4 independently represents hydrogen or C1-3alkyl. A pharmaceutical composition, a method of a mixed complex metal compound and a treatment method are also proposed.

EFFECT: improved treatment of pathological conditions caused by the presence of free radicals generated by oxygen.

26 cl, 35 dwg, 11 ex

Similar patents RU2622646C2

Title Year Author Number
KALMANGAFODIPIR, NEW CHEMICAL COMPOUND, AND OTHER MIXED COMPLEX COMPOUNDS WITH METALS, METHODS FOR PRODUCTION, COMPOSITIONS AND METHODS FOR TREATMENT 2012
  • Karlsson Jan Olof
  • Reineke Karl
  • Kurz Tino
  • Andersson Rolf
  • Hall Michael
  • Mclaughlin Christina
  • Jacobsson Sven
  • Naesstroem Jacques
RU2765805C2
PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS IMPLYING APPLICATION OF COMBINATION OF COMPLEX COMPOUND OF MANGANESE AND COMPOUND IN FORM OTHER THAN MANGANESE COMPLEX 2010
  • Karlsson Jan-Olof
  • Andersson Rol'F
RU2563825C2
COMPOUNDS FOR TREATING CANCER 2008
  • Karlsson Jan Olof G.
  • Kurts Tino
  • Andersson Rol'F
RU2491282C2
COMBINED THERAPY FOR CANCER TREATMENT 2015
  • Bao, Xingfeng
  • Albu, Diana
  • Woodall-Jappe, Mary
RU2708374C2
NOVEL ANTITUMOR COMPOUNDS 2003
  • Fehrklot Glinn Tomas
  • Ehlises Mar'Jano
  • Sasak Khalina
  • Aviles Marin Pablo Manuehl'
  • Kuehvas Marchante Marija Del' Karmen
RU2356908C2
COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER WITH ARGININE-DEPLETING AND IMMUNE-ONCOLOGICAL AGENTS 2017
  • Lowe, David
  • Rowlinson, Scott, W.
  • Alters, Susan
  • Agnello, Giulia
RU2771313C2
COMBINATION OF TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, ANTITUMOR PLATINUM COMPLEX, AND MODULATOR OF CONTROL POINTS OF IMMUNE RESPONSE 2018
  • Abastado Jean-Pierre
  • Amellal Nadia
  • Bruno Alain
  • Burbridge Michael Frank
  • Cattan Valerie
  • Leger Catherine
RU2778887C2
COMBINATION THERAPY USING CC CHEMOKINE RECEPTOR 4 (CCR4) ANTAGONISTS AND ONE OR MORE CHECKPOINT INHIBITORS 2019
  • Li, Shijie
  • Mali, Venkat Reddy
  • Singh, Rajinder
  • Yang, Ju
  • Zhang, Penglie
RU2810717C2
THERAPEUTIC USES OF ARSENIC AND POSSIBLE MECHANISMS OF ACTION 2020
  • Rieger, Francois
  • Batteux, Frederic
RU2815051C2
COMBINED ANTICANCER THERAPY AND PHARMACEUTICAL COMPOSITIONS THEREFOR 2005
  • Boer Zhak Alen
  • K'Javaroli Karlo
RU2396960C2

RU 2 622 646 C2

Authors

Karlsson Yan Olof

Reineke Karl

Kurts Tino

Andersson Rolf

Kholl Majkl

Maklaflin Kristina

Yakobsson Sven

Nesstrem Zhak

Dates

2017-06-19Published

2012-12-04Filed